These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 25655755)

  • 1. Worldwide study links two new genetic variants to breast cancer.
    Mayor S
    BMJ; 2015 Feb; 350():h653. PubMed ID: 25655755
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-wide association studies and the clinic: a focus on breast cancer.
    Véron A; Blein S; Cox DG
    Biomark Med; 2014; 8(2):287-96. PubMed ID: 24521025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond BRCA1/2: polygenic, 'polyfunctional' molecular circuitry model to predict breast cancer risk.
    Lianos GD; Zoras O; Roukos DH
    Biomark Med; 2013 Oct; 7(5):675-8. PubMed ID: 24044557
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
    Fehringer G; Boyd NF; Knight JA; Paterson AD; Dite GS; Giles GG; Southey MC; Andrulis IL; Hopper JL; Ozcelik H
    Breast Cancer Res Treat; 2009 Nov; 118(2):415-24. PubMed ID: 19229608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations.
    van Zitteren M; van der Net JB; Kundu S; Freedman AN; van Duijn CM; Janssens AC
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):9-22. PubMed ID: 21212067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2-negative breast cancer limitations and next-generation sequencing technology promises.
    Baltogiannis G; Katsios C; Zografos GC; Roukos DH
    Ann Surg Oncol; 2010 Jun; 17(6):1720. PubMed ID: 20198443
    [No Abstract]   [Full Text] [Related]  

  • 8. Using MLPA for large genomic rearrangements detection in breast cancer predisposition genes.
    Negură L; Carasevici E; Artenie V; Negură A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1182-90. PubMed ID: 20191896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep sequencing and integrative genome analysis: approaching a new class of biomarkers and therapeutic targets for breast cancer.
    Zografos G; Liakakos T; Roukos DH
    Pharmacogenomics; 2013 Jan; 14(1):5-8. PubMed ID: 23252942
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular forecasting of breast cancer: time to move forward with clinical testing.
    Loi S; Sotiriou C; Buyse M; Rutgers E; Van't Veer L; Piccart M; Cardoso F
    J Clin Oncol; 2006 Feb; 24(4):721-2; author reply 722-3. PubMed ID: 16446348
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenomics in breast cancer: current trends and future directions.
    Wajapeyee N; Somasundaram K
    Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer: a candidate gene approach across the estrogen metabolic pathway.
    Justenhoven C; Hamann U; Schubert F; Zapatka M; Pierl CB; Rabstein S; Selinski S; Mueller T; Ickstadt K; Gilbert M; Ko YD; Baisch C; Pesch B; Harth V; Bolt HM; Vollmert C; Illig T; Eils R; Dippon J; Brauch H
    Breast Cancer Res Treat; 2008 Mar; 108(1):137-49. PubMed ID: 17588204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial biomarker expression in breast cancer.
    Rakha EA; Reis-Filho JS; Ellis IO
    Breast Cancer Res Treat; 2010 Apr; 120(2):293-308. PubMed ID: 20107892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
    Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
    Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants associated with breast-cancer risk.
    Narod SA
    Lancet Oncol; 2011 May; 12(5):415-6. PubMed ID: 21514220
    [No Abstract]   [Full Text] [Related]  

  • 16. Ability to predict breast cancer in Asian women using a polygenic susceptibility model.
    Hartman M; Suo C; Lim WY; Miao H; Teo YY; Chia KS
    Breast Cancer Res Treat; 2011 Jun; 127(3):805-12. PubMed ID: 21153878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic biomarkers and breast cancer: cause for optimism.
    Visvanathan K; Sukumar S; Davidson NE
    Clin Cancer Res; 2006 Nov; 12(22):6591-3. PubMed ID: 17121875
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
    Peng S; Lü B; Ruan W; Zhu Y; Sheng H; Lai M
    Breast Cancer Res Treat; 2011 Jun; 127(2):309-24. PubMed ID: 21445572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk.
    Vaclavicek A; Bermejo JL; Wappenschmidt B; Meindl A; Sutter C; Schmutzler RK; Kiechle M; Bugert P; Burwinkel B; Bartram CR; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Dec; 106(2):205-13. PubMed ID: 17268814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond BRCA: new hereditary breast cancer susceptibility genes.
    Economopoulou P; Dimitriadis G; Psyrri A
    Cancer Treat Rev; 2015 Jan; 41(1):1-8. PubMed ID: 25467110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.